The Cohort Study of Uveitis Patients
Study Details
Study Description
Brief Summary
This study intends to explore the epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment of uveitis. This is a cohort study. The outcome of the study is the activity of inflammation and visual prognosis. The purpose of this study is to determine the optimal diagnosis and treatment scheme for uveitis patients based on real-world data.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Noninfectious uveitis
|
|
| Infectious uveitis
|
Outcome Measures
Primary Outcome Measures
- anterior chamber inflammation [12 months post-treatment]
activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
- inflammatory chorioretinal and/or inflammatory retinal vascular lesions [12 months post-treatment]
inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography
Secondary Outcome Measures
- Best corrected visual acuity [1 month post-treatment]
Best corrected visual acuity
- Best corrected visual acuity [3 months post-treatment]
Best corrected visual acuity
- Best corrected visual acuity [6 months post-treatment]
Best corrected visual acuity
- Best corrected visual acuity [12 months post-treatment]
Best corrected visual acuity
- Best corrected visual acuity [24 months post-treatment]
Best corrected visual acuity
- Best corrected visual acuity [36 months post-treatment]
Best corrected visual acuity
- Intraocular pressure [1 month post-treatment]
Intraocular pressure
- Intraocular pressure [3 months post-treatment]
Intraocular pressure
- Intraocular pressure [6 months post-treatment]
Intraocular pressure
- Intraocular pressure [12 months post-treatment]
Intraocular pressure
- Intraocular pressure [24 months post-treatment]
Intraocular pressure
- Intraocular pressure [36 months post-treatment]
Intraocular pressure
- Central retinal thickness [1 month post-treatment]
Central retinal thickness was evaluated by Optical Coherence Tomography
- Central retinal thickness [3 months post-treatment]
Central retinal thickness was evaluated by Optical Coherence Tomography
- Central retinal thickness [6 months post-treatment]
Central retinal thickness was evaluated by Optical Coherence Tomography
- Central retinal thickness [12 months post-treatment]
Central retinal thickness was evaluated by Optical Coherence Tomography
- Central retinal thickness [24 months post-treatment]
Central retinal thickness was evaluated by Optical Coherence Tomography
- Central retinal thickness [36 months post-treatment]
Central retinal thickness was evaluated by Optical Coherence Tomography
- anterior chamber inflammation [1 month post-treatment]
activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
- anterior chamber inflammation [3 months post-treatment]
activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
- anterior chamber inflammation [6 months post-treatment]
activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
- anterior chamber inflammation [24 months post-treatment]
activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
- anterior chamber inflammation [36 months post-treatment]
activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
- inflammatory chorioretinal and/or inflammatory retinal vascular lesions [3 months post-treatment]
inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography
- inflammatory chorioretinal and/or inflammatory retinal vascular lesions [6 months post-treatment]
inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography
- inflammatory chorioretinal and/or inflammatory retinal vascular lesions [24 months post-treatment]
inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography
- inflammatory chorioretinal and/or inflammatory retinal vascular lesions [36 months post-treatment]
inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography
Eligibility Criteria
Criteria
Inclusion Criteria:
- The diagnosis is uveitis; The agreement of enrolling this study;
Exclusion Criteria:
- Uveitis during the first month after any intraocular surgery; <18 years; pregnant and lactating women; other conditions are unsuitable for participation in this study by the investigator such as mental abnormalities.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Zhongshan Ophthalmic Center | Guangzhou | Guangdong | China |
Sponsors and Collaborators
- Zhongshan Ophthalmic Center, Sun Yat-sen University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IIT2022146